Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice

Lucia Recinella(University of Chieti-Pescara), Sheila Leone(University of Chieti-Pescara), Riccarda Granata(University of Turin), Wei Sha(University of Miami), Rossano Lattanzio(University of Chieti-Pescara), Annalisa Chiavaroli(University of Chieti-Pescara), Serena Veschi(University of Chieti-Pescara), Claudio Ferrante(University of Chieti-Pescara), Andrew V. Schally(University of Miami), Giustino Orlando(University of Chieti-Pescara), Luigi Brunetti(University of Chieti-Pescara), Iacopo Gesmundo(University of Turin), Renzhi Cai(University of Miami), Valentina Di Valerio(University of Chieti-Pescara)
Biomedicine & Pharmacotherapy
December 16, 2021
10.1016/j.biopha.2021.112554
Cited by 19

Related Papers

Induction of bilirubin clearance by the constitutive androstane receptor (CAR)
|Proceedings of the National Academy of Sciences|2003|385
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)
|Journal of Endocrinological Investigation|2019|292
Acylated and Unacylated Ghrelin Promote Proliferation and Inhibit Apoptosis of Pancreatic β-Cells and Human Islets: Involvement of 3′,5′-Cyclic Adenosine Monophosphate/Protein Kinase A, Extracellular Signal-Regulated Kinase 1/2, and Phosphatidyl Inositol 3-Kinase/Akt Signaling
|Endocrinology|2006|290
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
|European Journal of Pharmacology|2006|284
Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases
|Frontiers in Physiology|2020|264